Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Department of Neurology, Klinikum Osnabrück, Am Finkenhügel 1, 49076 Osnabrück, Germany.
Int J Mol Sci. 2021 Sep 18;22(18):10087. doi: 10.3390/ijms221810087.
Vitamin E is often associated with health benefits, such as antioxidant, anti-inflammatory and cholesterol-lowering effects. These properties make its supplementation a suitable therapeutic approach in neurodegenerative disorders, for example, Alzheimer's or Parkinson's disease. However, trials evaluating the effects of vitamin E supplementation are inconsistent. In randomized controlled trials, the observed associations often cannot be substantiated. This could be due to the wide variety of study designs regarding the dosage and duration of vitamin E supplementation. Furthermore, genetic variants can influence vitamin E uptake and/or metabolism, thereby distorting its overall effect. Recent studies also show adverse effects of vitamin E supplementation regarding Alzheimer's disease due to the increased synthesis of amyloid β. These diverse effects may underline the inhomogeneous outcomes associated with its supplementation and argue for a more thoughtful usage of vitamin E. Specifically, the genetic and nutritional profile should be taken into consideration to identify suitable candidates who will benefit from supplementation. In this review, we will provide an overview of the current knowledge of vitamin E supplementation in neurodegenerative disease and give an outlook on individualized, sustainable neuro-nutrition, with a focus on vitamin E supplementation.
维生素 E 通常与健康益处相关,如抗氧化、抗炎和降低胆固醇的作用。这些特性使其补充成为神经退行性疾病(如阿尔茨海默病或帕金森病)的一种合适的治疗方法。然而,评估维生素 E 补充剂效果的试验结果并不一致。在随机对照试验中,观察到的关联往往无法得到证实。这可能是由于关于维生素 E 补充剂的剂量和持续时间的研究设计多种多样。此外,遗传变异可以影响维生素 E 的摄取和/或代谢,从而扭曲其整体效果。最近的研究还表明,由于淀粉样蛋白 β的合成增加,维生素 E 补充剂对阿尔茨海默病有不良影响。这些不同的影响可能强调了与补充相关的不均匀结果,并呼吁更谨慎地使用维生素 E。具体来说,应该考虑遗传和营养状况,以确定从补充中受益的合适候选者。在这篇综述中,我们将概述维生素 E 补充在神经退行性疾病中的现有知识,并展望个体化、可持续的神经营养,重点是维生素 E 补充。